Cytokines and Costimulatory Molecules in the Immune Response to Murine Gammaherpesvirus-68

Viral Immunology

Volumn 17, Issue 1, 2004, Pages 3-11

  Sarawar, Sally R ^a   Lee, Bong Joo ^b   Giannoni, Francesca ^a  

^a TORREY PINES INSTITUTE FOR MOLECULAR STUDIES   (United States)

^b Chonnam National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CD4 ANTIGEN; CD40 ANTIGEN; CD8 ANTIGEN; CYTOKINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HERPES VIRUS; IMMUNE RESPONSE; IMMUNITY; INFECTION CONTROL; LEUKOCYTE; MOUSE; MURINE GAMMAHERPESVIRUS 68; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; REVIEW; T LYMPHOCYTE; VIRUS INFECTION; VIRUS STRAIN;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD28; ANTIGENS, CD40; CD40 LIGAND; CYTOKINES; GAMMAHERPESVIRINAE; HERPESVIRIDAE INFECTIONS; MICE; T-LYMPHOCYTES;

ANIMALIA; DNA VIRUSES; HERPESVIRIDAE; MURINAE; MURINE HEPATITIS VIRUS;

EID: 1542408547     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/088282404322875412     Document Type: Review

References (66)

1. Alber, D.G., K.L. Powell, P. Vallance, et al. 2000. Herpesvirus infection accelerates atherosclerosis in the apolipoprotein E-deficient mouse. Circulation 102:779-785.
2. Alexander, J.M., C.A. Nelson, V. van Berkel, et al. 2002. H. Structural basis of chemokine sequestration by a herpesvirus decoy receptor. Cell 111:343-356.
3. Allison, J.P. 1994. CD28-B7 interactions in T-cell activation. Curr. Opin. Immunol. 6:414-419.
4. Arvanitakis, L., E. Geras-Raaka, A. Varma, et al. 1997. Human herpesvirus KSHV encodes a constitutively active G-protein-coupled receptor linked to cell proliferation. Nature 385:347-350.
5. Bais, C., B. Santomasso, O. Coso, et al. 1998. G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator. Nature 391:86-89.
6. Banks, T.A., B.T. Rouse, M.K. Kerley, et al. 1995. Lymphotoxin-a-deficient mice. Effects on secondary lymphoid organ development and humoral immune responsiveness. J. Immunol. 155:1685-1693.
7. Bennett, S.R., F.R. Carbone, F. Karamalis, et al. 1998. Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature 393:478-480.
8. Blaskovic, D., M. Stancekova, J. Svobodova, et al. 1980. Isolation of five strains of herpesviruses from two species of free living small rodents. Acta Virol. 24:468.
9. Bridgeman, A., P.G. Stevenson, J.P. Simas, et al. 2001. A secreted chemokine binding protein encoded by murine gammaherpesvirus-68 is necessary for the establishment of a normal latent load. J. Exp. Med. 194:301-312.
10. Brooks, J.W., A.M. Hamilton-Easton, J.P. Christensen, et al. 1999. Requirement for CD40 ligand, CD4+ T cells, and B cells in an infectious mononucleosis-like syndrome. J. Virol. 73:9650-9654.
11. Cardin, R.D., J.W. Brooks, S.R. Sarawar, et al. 1996. Progressive loss of CD8+ T cell-mediated control of a τ-herpesvirus in the absence of CD4+ T cells. J. Exp. Med. 184:863-871.
12. Cesarman, E., E.A. Mesri, and M. Gershengorn. 2000. Viral G protein-coupled receptor and Kaposi's sarcoma: a model of paracrine neoplasia? J. Exp. Med. 191:417-422.
13. Cesarman, E., R.G. Nador, F. Bai, F., et al. 1996. Kaposi's sarcoma-associated herpesvirus contains G protein-coupled receptor and cyclin D homologs which are expressed in Kaposi's sarcoma and malignant lymphoma. J. Virol. 70:8218-8223.
14. Chaplin, D., and Y.-X. Fu. Cytokine regulation of secondary lymphoid organ development. Curr. Opin. Immunol. 10:289-297.
15. Christensen, J.P., R.D. Cardin, K.C. Branum, et al. CD4+ T cell-mediated control of a gamma-herpesvirus in B cell-deficient mice is mediated by IFN-gamma. 1999. Proc. Natl. Acad. Sci. USA 96:5135-5140.
16. De Togni, P., J. Goellner, N.H. Ruddle, et al. 1994. Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin. Science 264:703-706.
17. Doherty, P.C., D.J. Topham, R.A. Tripp, et al. 1997. Effector CD4+ and CD8+ T-cell mechanisms in the control of respiratory virus infections. Immunol. Rev. 159:105-117.
18. Dutia, B.M., D.J. Allen, H. Dyson, et al. 1999. Type I interferons and IRF-1 play a critical role in the control of a gammaherpesvirus infection. Virology 261:173-179.
19. Dutia, B.M., C.J. Clarke, D.J. Allen, et al. 1997. Pathological changes in the spleens of gamma interferon receptor-deficient mice infected with murine gammaherpesvirus: a role for CD8 T cells. J. Virol. 71:4278-4283.
20. Ebrahimi, B., B.M. Dutia, D.G. Brownstein, et al. 2001. Murine gammaherpesvirus-68 infection causes multi-organ fibrosis and alters leukocyte trafficking in interferon-gamma receptor knockout mice. Am. J. Pathol. 158:2117-2125.
21. Efstathiou, S., Y.M. Ho, and A.C. Minson. 1990. Cloning and molecular characterization of the murine herpesvirus 68 genome. J. Gen. Virol. 71:1355-1364.
22. Ehtisham, S., N.P. Sunil Chandra, and A.A. Nash. 1993. Pathogenesis of murine gammaherpesvirus infection in mice deficient in CD4 and CD8 T cells. J. Virol. 67:5247-5252.
23. Fu, Y.-X., and D. Chaplin. 1999. Development and maturation of secondary lymphoid tissues. Annu. Rev. Immunol. 17:399-433.
24. Gangappa, S., S.B. Kapadia, S.H. Speck, et al. 2002. Antibody to a lytic cycle viral protein decreases gammaherpesvirus latency in B-cell-deficient mice. J. Virol. 76:11460-11468.
25. Gilman, S.C., and R.J. Noelle. 1998. Molecular mechanisms of costimulation. Agents Actions Suppl. 49:15-16.
26. Janeway, C.A., Jr., and K. Bottomly. 1994. Signals and signs for lymphocyte responses. Cell 76:275-285.
27. Jenkins, M.K. 1994. The ups and downs of T cell costimulation. Immunity 1:443-446.
28. Kim, I.J., E. Flano, D.L. Woodland, et al. 2002. Antibody-mediated control of persistent gamma-herpesvirus infection. J. Immunol. 168:3958-3964.
29. Kirshner, J.R., K. Staskus, A. Haase, et al. 1999. Expression of the open reading frame 74 (G-protein-coupled receptor) gene of Kaposi's sarcoma (KS)-associated herpesvirus: implications for KS pathogenesis. J. Virol. 73:6006-6014.
30. Lee, B.J., U.H. Koszinowski, S.R. Sarawar, et al. 2003. A gammaherpesvirus G protein-coupled receptor homologue is required for increased viral replication in response to chemokines and efficient reactivation from latency. J. Immunol. 170:243-251.
31. Lee, B.J., S.K. Reiter, M. Anderson, et al. 2002. CD28(-/-) mice show defects in cellular and humoral immunity but are able to control infection with murine gammaherpesvirus 68. J. Virol. 76:3049-3053.
32. Lee, B.J., S. Santee, S. Von Gesjen, et al. 2000. Lymphotoxin-alpha-deficient mice can clear a productive infection with murine gammaherpesvirus 68 but fail to develop splenomegaly or lymphocytosis. J. Virol. 74:2786-2792.
33. Mackey, M.F., R.J. Barth, Jr., and R.J. Noelle. 1998. The role of CD40/CD154 interactions in the priming, differentiation, and effector function of helper and cytotoxic T cells. J. Leukoc. Biol. 63:418-428.
34. Mariathasan, S., M. Matsumoto, F. Baranyay, et al. 1995. Absence of lymph nodes in lymphotoxin-a(LT-a)-deficient mice is due to abnormal organ development, not defective lymphocyte migration. J. Inflammation 45:72-78.
35. Martin, D.F., B.D. Kuppermann, R.A. Wolitz, et al. 1999. Oral ganciclovir for patients with cytomegalovirus retinitis treated with a ganciclovir implant. Roche Ganciclovir Study Group. N. Engl. J. Med. 340:1063-1070.
36. Matloubian, M., R.J. Concepcion, and R. Ahmed. 1994. CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection. J. Virol. 68:8056-8063.
37. Matsumoto, M., S.F. Lo, C.J.L. Carruthers, et al. 1996. Affinity maturation without germinal centers in lymphotoxin-α-deficient mice. Nature 382:462-466.
38. Moorman, N.J., H.W. Virgin IV, and S.H. Speck. 2003. Disruption of the gene encoding the gammaHV68 v-GPCR leads to decreased efficiency of reactivation from latency. Virology 111:179-190.
39. Parry, C.M., J.P. Simas, V.P. Smith, et al. 2000. A broad-spectrum secreted chemokine binding protein encoded by a herpesvirus. J. Exp. Med. 191:573-578.
40. Peacock, J.W., and K.L. Bost. 2001. Murine gammaherpesvirus-68-induced interleukin-10 increases viral burden, but limits virus-induced splenomegaly and leukocytosis. Immunology 104:109-117.
41. Ridge, J.P., F. Di Rosa, and P. Matzinger. 1998. A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell. Nature 393:474-478.
42. Sarawar, S.R., J.W. Brooks, R.D. Cardin, et al. 1998. Pathogenesis of murine gammaherpesvirus-68 infection in interleukin-6-deficient mice. Virology 249:359-366.
43. Sarawar, S.R., R.D. Cardin, J.W. Brooks, et al. 1997. Gamma interferon is not essential for recovery from acute infection with murine gammaherpesvirus 68. J. Virol. 71:3916-3921.
44. Sarawar, S.R., R.D. Cardin, J.W. Brooks, et al. 1996. Cytokine production in the immune response to murine gammaherpesvirus 68. J. Virol. 70:3264-3268.
45. Sarawar, S.R., B.J. Lee, M. Anderson, et al. 2002. Chemokine induction and leukocyte trafficking to the lungs during murine gammaherpesvirus 68 (MHV-68) infection. Virology 293:54-62.
46. Sarawar, S.R., B.J. Lee, S.K. Reiter, et al. 2001. Stimulation via CD40 can substitute for CD4 T cell function in preventing reactivation of a latent herpesvirus. Proc. Natl. Acad. Sci. USA 98:6325-6329.
47. Schoenberger, S.P., R.E. Toes, E.I. van der Voort, et al. 1998. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 393:480-483.
48. Shlomchik, W.D., M.S. Couzens, C.B. Tang, et al. 1999. Prevention of graft versus host disease by inactivation of host antigen-presenting cells. Science 285:412-415.
49. Stevenson, P.G., R.D. Cardin, J.P. Christensen, et al. 1999. Immunological control of a murine gammaherpesvirus independent of CD8+ T cells. J. Gen. Virol. 80:477-483.
50. Stewart, J.P., E.J. Usherwood, A. Ross, et al. 1998. Lung epithelial cells are a major site of murine gammaherpesvirus persistence. J. Exp. Med. 187:1941-1951.
51. Stiehm, E.R., T.W. Chin, A. Haas, et al. 1986. Infectious complications of the primary immunodeficiencies. Clin. Immunol. Immunopathol. 40:69-86.
52. Sunil Chandra, N.P., J. Arno, J. Fazakerley, et al. 1994. Lymphoproliferative disease in mice infected with murine gammaherpesvirus 68. Am. J. Pathol. 145:818-826.
53. Sunil Chandra, N.P., S. Efstathiou, J. Arno, et al. 1992. Virological and pathological features of mice infected with murine gamma-herpesvirus 68. J. Gen. Virol. 73:2347-2356.
54. Topham, D.J., R.C. Cardin, J.P. Christensen, et al. 2001. Perforin and Fas in murine gammaherpesvirus-specific CD8(+) T cell control and morbidity. J. Gen. Virol. 82:1971-1981.
55. Tripp, R.A., A.M. Hamilton-Easton, R.D. Cardin, et al. 1997. Pathogenesis of an infectious mononucleosis-like disease induced by a murine gamma-herpesvirus: role for a viral superantigen? J. Exp. Med. 185:1641-1650.
56. Tripp, R.A., S.R. Sarawar, and P.C. Doherty. 1995. Characteristics of the influenza virus-specific CD8+ T cell response in mice homozygous for disruption of the H-21Ab gene. J. Immunol. 155:2955-2959.
57. Usherwood, E.J., J.W. Brooks, S.R. Sarawar, et al. 1997. Immunological control of murine gammaherpesvirus infection is independent of perforin. J. Gen. Virol. 78:2025-2030.
58. Usherwood, E.J., J.P. Stewart, K. Robertson, et al. 1996. Absence of splenic latency in murine gammaherpesvirus 68-infected B cell-deficient mice. J. Gen. Virol. 77:2819-2825.
59. van Berkel, V., J. Barrett, H.L. Tiffany, et al. 2000. Identification of a gammaherpesvirus selective chemokine binding protein that inhibits chemokine action. J. Virol. 74:6741-6747.
60. van Berkel, V., B. Levine, S.B. Kapadia, et al. 2002. Critical role for a high-affinity chemokine-binding protein in gamma-herpesvirus-induced lethal meningitis. J. Clin. Invest. 109:905-914.
61. van Berkel, V., K. Preiter, H.W. Virgin, IV, et al. 1999. Identification and initial characterization of the murine gammaherpesvirus 68 gene M3, encoding an abundantly secreted protein. J. Virol. 73:4524-4529.
62. Virgin, H.W., P. Latreille, P. Wamsley, et al. 1997. Complete sequence and genomic analysis of murine gammaherpesvirus 68. J. Virol. 71:5894-5904.
63. Wakeling, M.N., D.J. Roy, A.A. Nash, et al. 2001. Characterization of the murine gammaherpesvirus 68 ORF74 product: a novel oncogenic G protein-coupled receptor. J. Gen. Virol. 82:1187-1197.
64. Weck, K.E., A.J. Dal Canto, J.D. Gould, et al. 1997. Murine τ-herpesvirus 68 causes severe large-vessel arteritis in mice lacking interferon-τ responsiveness: a new model for virus-induced vascular disease. Nat. Med. 3:1346-1353.
65. Weck, K.E., S.S. Kim, H.W. Virgin IV, et al. 1999. Macrophages are the major reservoir of latent murine gammaherpesvirus 68 in peritoneal cells. J. Virol. 73:3273-3283.
66. Weinberg, J.B., M.L. Lutzke, S. Efstathiou, et al. 2002. Elevated chemokine responses are maintained in lungs after clearance of viral infection. J. Virol. 76:10518-10523.